Clinical Trials Browser

Phase 1/2 × Breast Neoplasms, Male × Sunitinib × Clear all

NCT00616122 2020-01-13

Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast Cancer

Phase 1/2 Terminated

32 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male